- Home
- RVPH vs RGS Comparison
RVPH vs RGS Comparison
Compare RVPH & RGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- RGS
- Stock Information
- Founded
- RVPH 2006
- RGS 1922
- Country
- RVPH United States
- RGS United States
- Employees
- RVPH N/A
- RGS N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- RGS Other Consumer Services
- Sector
- RVPH Health Care
- RGS Consumer Discretionary
- Exchange
- RVPH Nasdaq
- RGS Nasdaq
- Market Cap
- RVPH 50.0M
- RGS 53.6M
- IPO Year
- RVPH N/A
- RGS 1991
- Fundamental
- Price
- RVPH $1.78
- RGS $26.12
- Analyst Decision
- RVPH Strong Buy
- RGS
- Analyst Count
- RVPH 4
- RGS 0
- Target Price
- RVPH $15.33
- RGS N/A
- AVG Volume (30 Days)
- RVPH 5.1M
- RGS 36.3K
- Earning Date
- RVPH 11-14-2024
- RGS 01-29-2025
- Dividend Yield
- RVPH N/A
- RGS N/A
- EPS Growth
- RVPH N/A
- RGS N/A
- EPS
- RVPH N/A
- RGS 37.55
- Revenue
- RVPH N/A
- RGS $195,670,000.00
- Revenue This Year
- RVPH N/A
- RGS N/A
- Revenue Next Year
- RVPH N/A
- RGS N/A
- P/E Ratio
- RVPH N/A
- RGS $0.72
- Revenue Growth
- RVPH N/A
- RGS N/A
- 52 Week Low
- RVPH $0.60
- RGS $3.87
- 52 Week High
- RVPH $5.67
- RGS $35.50
- Technical
- Relative Strength Index (RSI)
- RVPH 53.02
- RGS 61.39
- Support Level
- RVPH $1.23
- RGS $21.49
- Resistance Level
- RVPH $1.75
- RGS $24.35
- Average True Range (ATR)
- RVPH 0.53
- RGS 1.88
- MACD
- RVPH -0.07
- RGS 0.26
- Stochastic Oscillator
- RVPH 18.57
- RGS 82.09
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.
About RGS Regis Corporation
Regis Corp owns, franchises, and operates beauty salons throughout North America and the United Kingdom. The company's locations provide salon products and services to the mass market, including haircutting, styling, and hair coloring. The vast majority of Regis' salons are in strip malls, shopping centers, and Wal-Mart stores in North America and serve price-conscious customers. The company derives the majority of its revenue from these locations. The sale of products also contributes a relatively significant percentage of total sales. Regis also operates a smaller portfolio of premium salons across North America and the U.K. The company's majority brands include SmartStyle, Cost Cutters, and Supercuts.